Horien Biochemical Technology (7814) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 海昌生技

Horien Biochemical Technology (7814) reported revenue of NT$4.7 million for Oct 2026, -7.4% year on year and -44.2% from the previous month. Revenue for Jan–Oct 2026 was NT$82.3 million (+35.8% year on year).

In Oct 2026, it ranked No. 139 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$5.1 million24/10Nov 2024 NT$8.7 millionDec 2024 NT$16.5 millionJan 2025 NT$3.8 millionFeb 2025 NT$3.3 million25/02Mar 2025 NT$7.5 millionApr 2025 NT$5.2 millionMay 2025 NT$6.4 millionJun 2025 NT$4.8 million25/06Jul 2025 NT$10 millionAug 2025 NT$6.3 millionSep 2025 NT$8.2 millionOct 2025 NT$5.1 million25/10Nov 2025 NT$10.1 millionDec 2025 NT$12.3 millionJan 2026 NT$4.8 millionFeb 2026 NT$2.9 million26/02Mar 2026 NT$16 millionApr 2026 NT$5.4 millionMay 2026 NT$4.5 millionJun 2026 NT$14.8 million26/06Jul 2026 NT$13.7 millionAug 2026 NT$7.1 millionSep 2026 NT$8.5 millionOct 2026 NT$4.7 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$4.7 million-7.4%-44.2%
Sep 2026NT$8.5 million+4.0%+19.1%
Aug 2026NT$7.1 million+12.7%-47.8%
Jul 2026NT$13.7 million+36.5%-7.2%
Jun 2026NT$14.8 million+209.3%+229.2%
May 2026NT$4.5 million-29.8%-16.3%
Apr 2026NT$5.4 million+3.3%-66.5%
Mar 2026NT$16 million+112.1%+452.8%
Feb 2026NT$2.9 million-13.6%-39.5%
Jan 2026NT$4.8 million+27.2%-61.2%
Dec 2025NT$12.3 million-25.3%+22.5%
Nov 2025NT$10.1 million+16.1%+96.5%
Oct 2025NT$5.1 million+1.4%-37.4%
Sep 2025NT$8.2 million-41.1%+29.0%
Aug 2025NT$6.3 million+0.7%-36.7%
Jul 2025NT$10 million-14.7%+110.2%
Jun 2025NT$4.8 million+4.3%-25.2%
May 2025NT$6.4 million+13.7%+23.1%
Apr 2025NT$5.2 million+43.8%-31.2%
Mar 2025NT$7.5 million-43.4%+125.2%
Feb 2025NT$3.3 million-15.5%-11.0%
Jan 2025NT$3.8 million-22.2%-77.2%
Dec 2024NT$16.5 million+973.3%+90.4%
Nov 2024NT$8.7 million—+71.6%
Oct 2024NT$5.1 million—-63.6%

Jan–Oct 2026 cumulative: NT$82.3 million (+35.8% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Horien Biochemical Technology vs PEC / Horien Biochemical Technology vs Lotus Pharm / Horien Biochemical Technology vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

主係客戶需求增加所致

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16